483 Merck & Co Oct 2013

483 Merck & Co Oct 2013

Gayle Lawson FDA$595.00 - Available Now

FDA investigators audited the Merck & Co - North Wales, PA, United States facility and issued inspectional observations (via FDA 483) on 08 Oct 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 08 Oct 2013
  • Location: North Wales, United States
  • FEI: 3002721810
Add To Cart